DK0803502T3 - Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater - Google Patents

Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater

Info

Publication number
DK0803502T3
DK0803502T3 DK97106476T DK97106476T DK0803502T3 DK 0803502 T3 DK0803502 T3 DK 0803502T3 DK 97106476 T DK97106476 T DK 97106476T DK 97106476 T DK97106476 T DK 97106476T DK 0803502 T3 DK0803502 T3 DK 0803502T3
Authority
DK
Denmark
Prior art keywords
optically active
preparation
carboxylic acid
acid derivatives
piperazine carboxylic
Prior art date
Application number
DK97106476T
Other languages
English (en)
Inventor
Rudolf Dr Fuchs
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Application granted granted Critical
Publication of DK0803502T3 publication Critical patent/DK0803502T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
DK97106476T 1996-04-23 1997-04-18 Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater DK0803502T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH102896 1996-04-23

Publications (1)

Publication Number Publication Date
DK0803502T3 true DK0803502T3 (da) 2002-09-23

Family

ID=4200769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97106476T DK0803502T3 (da) 1996-04-23 1997-04-18 Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater

Country Status (9)

Country Link
US (1) US5945534A (da)
EP (1) EP0803502B1 (da)
JP (1) JP4138906B2 (da)
AT (1) ATE219769T1 (da)
CA (1) CA2201218C (da)
DE (1) DE59707584D1 (da)
DK (1) DK0803502T3 (da)
ES (1) ES2179238T3 (da)
PT (1) PT803502E (da)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011995A (en) * 1987-07-28 1991-04-30 Ciba-Geigy Corporation Process for the preparation of optically active secondary amines
US4996361A (en) * 1987-07-30 1991-02-26 The University Of British Columbia Process for the preparation of optically active secondary arylamines
CA2081970C (en) * 1991-11-08 1997-07-08 Joseph P. Vacca Hiv protease inhibitors useful for the treatment of aids
SG42936A1 (en) * 1992-04-02 1997-10-17 Ciba Geigy Ag Ferrocenyl diphosphines as ligands for homogeneous catalysts
DE59410267D1 (de) * 1993-02-26 2003-05-15 Syngenta Participations Ag Ferrocenyldiphosphine als Liganden für homogene Katalysatoren
US5353193A (en) * 1993-02-26 1994-10-04 Lsi Logic Corporation High power dissipating packages with matched heatspreader heatsink assemblies
CZ293953B6 (cs) * 1993-07-16 2004-08-18 Mercká@Áco@Źáinc Způsob výroby meziproduktů pro výrobu inhibitorů HIV@proteázy a příslušné meziprodukty
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Formation and resolution of 2-tert-butylcarboxamido-piperazine
US5734055A (en) * 1993-11-22 1998-03-31 Koei Chemical Co. Ltd. Process for preparing N-tert-butyl-2-pyrazinecarboxamide and N-tert-butyl-2-piperazinecarboxamide
TW472047B (en) * 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
JPH07291943A (ja) * 1994-04-22 1995-11-07 Koei Chem Co Ltd 光学活性N−tert−ブチル−2−ピペラジンカルボキサミドを製造する方法
US5612484A (en) * 1995-05-18 1997-03-18 Merck & Co., Inc. Process for making HIV protease inhibitors
PT744401E (pt) * 1995-05-23 2002-05-31 Lonza Ag Processo para a producao de derivados de acido 2-piperazinocarboxilico opticamente activos
US5723615A (en) * 1995-06-28 1998-03-03 Merck & Co., Inc. Process for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide
GB2302690A (en) * 1995-06-28 1997-01-29 Merck & Co Inc Process for preparing chiral 1,4-diacyl-(S)-piperazine-2-carboxamides using a diene/chiral bisphosphine/rhodium or iridium hydrogenation catalyst

Also Published As

Publication number Publication date
DE59707584D1 (de) 2002-08-01
ES2179238T3 (es) 2003-01-16
US5945534A (en) 1999-08-31
CA2201218C (en) 2004-09-28
EP0803502B1 (de) 2002-06-26
CA2201218A1 (en) 1997-10-23
JPH1045726A (ja) 1998-02-17
PT803502E (pt) 2002-11-29
EP0803502A2 (de) 1997-10-29
EP0803502A3 (de) 1997-11-19
JP4138906B2 (ja) 2008-08-27
ATE219769T1 (de) 2002-07-15

Similar Documents

Publication Publication Date Title
DE69300043D1 (de) Substituierte Pipecoline-Säurederivate als HIV-Protease-Hemmer.
IL125378A0 (en) Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
TR199501253A2 (tr) Amino(tio) eter türevleri.
DK0882725T3 (da) Quinoloncarboxylsyrederivater eller deres salte
ATE184194T1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)- homoserinlacton
DK0789019T3 (da) Fremgangsmåde til fremstilling af oxoimidazoliniumsalte
DK0626961T3 (da) Fremgangsmåde til nitrosering
NO921159L (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
DK0803502T3 (da) Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater
ATE199902T1 (de) N-benzylpiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
ATE44745T1 (de) Pyrimido(2,1-b)benzothiazolderivate und ihre salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen.
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
DK0438813T3 (da) Nyt antibiotikum, deoxymulundocandin, en fremgangsmåde til dets fremstilling samt dets anvendelse som lægemiddel
PT953563E (pt) Processo para a preparacao de derivados de depsipeptidos e novos compostos intermediarios para essa preparacao
DK0782991T3 (da) Fremgangsmåde til fremstilling af 2-substituerede 5-chlorimidazol-4-carbaldehyder
ATE325793T1 (de) Benzyliden-gamma-butyrolactone, verfahren zu ihrer herstellung und ihre verwendung als uv- absorber
ATE212634T1 (de) Metalloproteaseinhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
TW346483B (en) Benzene derivatives
DE59606328D1 (de) Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlor-imidazol-4-carbaldehyden
AR006754A1 (es) Derivados de quinoxalina utiles en terapia
ATE396187T1 (de) Indolmethyl-n,n'-bisacylpiperazine als neurokininrezeptorantagonisten
ATE204582T1 (de) Von neurokininen abgeleitete pseudopeptide, verfahren für ihre herstellung und sie enthaltende pharmazeutische zubereitungen